<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00161941</url>
  </required_header>
  <id_info>
    <org_study_id>224</org_study_id>
    <nct_id>NCT00161941</nct_id>
  </id_info>
  <brief_title>Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216</brief_title>
  <official_title>Open-label Multicenter Phase 3B Follow-up Study to Investigate the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens One Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in the NeisVac-C Non-interference Study 216</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <brief_summary>
    <textblock>
      The primary aim of the study is to show that the antibody response to hepatitis B, acellular
      pertussis toxin and inactivated poliovirus antigens after the 4th vaccination with Hexavac®
      is not influenced by the concomitant administration of NeisVac-C.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2003</start_date>
  <completion_date>December 2003</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <enrollment>321</enrollment>
  <condition>Meningococcal Meninigitis, Serogroup C</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Study subjects who completed study 216 will be eligible for participation in this study if:

          -  they received all 3 vaccinations with Hexavac during study 216 and the 4th Hexavac
             vaccination outside the study

          -  the subject's parent(s)/legal guardian(s) understands the study and has provided
             written informed consent for his/her child's study participation;

          -  a blood draw was performed after the 3rd vaccination during study 216.

        Exclusion Criteria:

        Study subjects will be excluded from participation in this study if:

          -  they have received any vaccination containing hepatitis B, poliovirus or acellular
             pertussis toxin antigens other than Hexavac

          -  they have received a blood transfusion or immunoglobulins during the period from 28
             days prior to the 4th Hexavac vaccination until study entry

          -  they have received another vaccine during the period from 28 days prior to the 4th
             Hexavac vaccination until study entry

          -  they are concurrently participating in or have participated in a clinical trial with
             an investigational medicinal product since the completion of study 216

          -  they suffer from a disease (e.g. autoimmune disease) or were undergoing a form of
             treatment that may be expected to influence immunological functions since the
             completion of study 216

          -  they have received systemic corticosteroids during the period from 28 days prior to
             the 4th Hexavac vaccination until study entry.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Months</minimum_age>
    <maximum_age>22 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulrich Behre, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Private practice, Hauptstrasse, Kehl, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Grieskirchner Strasse 17</name>
      <address>
        <city>Wels</city>
        <zip>4600</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neuschwansteinstrasse 5</name>
      <address>
        <city>Augsburg</city>
        <zip>86163</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marktplatz 3</name>
      <address>
        <city>Bad Saulgau</city>
        <zip>88348</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hauptrasse 9</name>
      <address>
        <city>Bietigheim-Bissingen</city>
        <zip>74321</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rheinstrasse13</name>
      <address>
        <city>Ettenheim</city>
        <zip>77955</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Solothurner Strasse 2</name>
      <address>
        <city>Heilbronn</city>
        <zip>74072</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hauptrasse 240</name>
      <address>
        <city>Kehl</city>
        <zip>77694</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Löpsinger Strasse 8</name>
      <address>
        <city>Nördlingen</city>
        <zip>86720</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tuchbergstrass 2</name>
      <address>
        <city>Oberndorf / Neckar</city>
        <zip>78727</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Falkensteiner Str. 24</name>
      <address>
        <city>Roding</city>
        <zip>93426</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Berneckstrasse 19</name>
      <address>
        <city>Schrammberg</city>
        <zip>78713</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2005</study_first_posted>
  <last_update_submitted>May 20, 2015</last_update_submitted>
  <last_update_submitted_qc>May 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2015</last_update_posted>
  <keyword>Meningococcal Vaccine</keyword>
  <keyword>Meningococcal Meningitis, Serogroup C</keyword>
  <keyword>Neisseria Meningitidis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis B</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antibodies</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

